Key Metrics
1.4
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
39
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
Q4
Pharmacology
SJR
- Q4 Pharmacology
- Q4 Drug Discovery
- Q4 Cancer Research
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.39
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Indexed in the following public directories
-
SJR
Journal Specifications
| Overview | |
| Publisher | OLD CITY PUBLISHING INC |
| Language | English |
| Frequency | Semi-annual |
| General Details | |
| Language | English |
| Frequency | Semi-annual |
| Publication Start Year | 1996 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Journal of Experimental Therapeutics and Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Alteration of the fragile histidine triad gene early in carcinogenesis: an update.
- 1 Nov 03
- Journal of experimental therapeutics & oncology
-
Full paper
Clinical applications of DNA microarray analysis.
- 1 Nov 03
- Journal of experimental therapeutics & oncology
-
Full paper
Keyword Index
- 1 Nov 03
- Journal of Experimental Therapeutics and Oncology
-
Full paper
Vanadium suppresses sister-chromatid exchange and DNA-protein crosslink formation and restores antioxidant status and hepatocellular architecture during 2-acetylaminofluorene-induced experimental rat hepatocarcinogenesis.
- 1 Nov 03
- Journal of experimental therapeutics & oncology
-
Full paper
Small cell lung cancer: from molecular biology to novel therapeutics.
- 1 Nov 03
- Journal of experimental therapeutics & oncology
-
Full paper
Author Index
- 1 Nov 03
- Journal of Experimental Therapeutics and Oncology
Scite analysis
Powered by scite_
135 articles received 1.3k citations see all
- 45 Supporting
- 1,246 Mentioning
- 4 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 0 Corrections
- 0 Errata
- 0 Expression of Concern
FAQs
How long has Journal of Experimental Therapeutics and Oncology been actively publishing?
Journal of Experimental Therapeutics and Oncology has been in operation since 1996 till date.
What is the publishing frequency of Journal of Experimental Therapeutics and Oncology ?
Journal of Experimental Therapeutics and Oncology published with a Semi-annual frequency.
What is the eISSN & pISSN for Journal of Experimental Therapeutics and Oncology ?
For Journal of Experimental Therapeutics and Oncology,eISSN is 1533-869X and pISSN is1359-4117.
What is Citescore for Journal of Experimental Therapeutics and Oncology ?
Citescore for Journal of Experimental Therapeutics and Oncology is 1.4.
What is H index for Journal of Experimental Therapeutics and Oncology ?
H index for Journal of Experimental Therapeutics and Oncology is 39.
What is SNIP score for Journal of Experimental Therapeutics and Oncology ?
SNIP score for Journal of Experimental Therapeutics and Oncology is 0.39.
What is the SJR for Journal of Experimental Therapeutics and Oncology ?
SJR for Journal of Experimental Therapeutics and Oncology is Q4.
Who is the publisher of Journal of Experimental Therapeutics and Oncology ?
OLD CITY PUBLISHING INC is the publisher of Journal of Experimental Therapeutics and Oncology.